Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
23
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Gonzales Roy | Senior VP, Finance | 11 | $0 | $0 | 2026-03-04 |
| Forman Mark S | Chief Medical Officer | 7 | $0 | $0 | 2026-03-04 |
| Mohan Raju | Chief Executive Officer | 67 | $962.1K | $18.05M | 2026-03-04 |
| Nuss John | Chief Scientific Officer | 80 | $0 | $6.76M | 2026-03-04 |
| Moore Matthew Richard | Chief Operating Officer | 4 | $0 | $0 | 2026-03-04 |
| Cadoret-Manier Onaiza | Director | 11 | $0 | $0 | 2026-03-04 |
| White William Richard | Director | 17 | $0 | $1.17M | 2026-03-04 |
| Gujrathi Sheila | Director | 21 | $300.3K | $3.37M | 2026-03-04 |
| HULME ALLISON | Director | 11 | $0 | $0 | 2026-03-04 |
| Subramaniam Somu | Director, 10% Owner | 58 | $0 | $45.58M | 2026-03-04 |
| NSV Partners III GP LLC | 10% Owner | 9 | $0 | $4.10M | 2024-06-24 |
| Auster Martin | Chief Financial Officer | 34 | $0 | $7.61M | 2024-04-02 |
| Krueger Christopher W | Chief Business Officer | 65 | $0 | $6.76M | 2024-04-02 |
| NSV Partners III LP | 10% Owner | 33 | $0 | $41.48M | 2023-09-18 |
| Sandborn William J. | See Remarks | 43 | $0 | $4.38M | 2023-08-31 |
| NSV Investments I, L.P. | 10% Owner | 1 | $0 | $0 | 2022-12-13 |
| Choksey Jigar | Director | 1 | $0 | $0 | 2022-06-09 |
| Gaster Richard | Director | 1 | $0 | $0 | 2022-06-09 |
| Royston Aaron | Director, 10% Owner | 6 | $5.00M | $0 | 2022-06-09 |
| Adelman Robert J | 10% Owner | 2 | $0 | $0 | 2022-06-09 |
| Drappa Jorn | Chief Medical Officer | 1 | $0 | $0 | 2022-02-04 |
| VENBIO GLOBAL STRATEGIC GP III, LTD | 10% Owner | 4 | $5.00M | $0 | 2021-10-25 |
| Chen Bihua | Other | 4 | $10.00M | $0 | 2021-10-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Forman Mark S | Chief Medical Officer | D To issuer deriv | 2026-03-04 | 2026-03-04 | 350,000 | — | $0 | 0 | SEC↗ |
| Forman Mark S | Chief Medical Officer | D To issuer deriv | 2026-03-04 | 2026-03-04 | 85,000 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | D To issuer deriv | 2026-03-04 | 2026-03-04 | 335,286 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | D To issuer deriv | 2026-03-04 | 2026-03-04 | 370,000 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | D To issuer deriv | 2026-03-04 | 2026-03-04 | 473,750 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | D To issuer deriv | 2026-03-04 | 2026-03-04 | 155,000 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | D To issuer deriv | 2026-03-04 | 2026-03-04 | 700,000 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | D To issuer deriv | 2026-03-04 | 2026-03-04 | 7,972 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | D To issuer deriv | 2026-03-04 | 2026-03-04 | 284,250 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | D To issuer deriv | 2026-03-04 | 2026-03-04 | 466,672 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | D To issuer deriv | 2026-03-04 | 2026-03-04 | 23,688 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-04 | 2026-03-04 | 145,000 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-04 | 2026-03-04 | 192,778 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-04 | 2026-03-04 | 9,063 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-04 | 2026-03-04 | 415,104 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-04 | 2026-03-04 | 108,750 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-04 | 2026-03-04 | 181,250 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-04 | 2026-03-04 | 125,000 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2026-03-04 | 2026-03-04 | 139,722 | — | $0 | 0 | SEC↗ |
| GUJRATHI SHEILA | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 15,937 | — | $0 | 0 | SEC↗ |
| GUJRATHI SHEILA | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 21,825 | — | $0 | 0 | SEC↗ |
| GUJRATHI SHEILA | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 33,000 | — | $0 | 0 | SEC↗ |
| GUJRATHI SHEILA | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 40,000 | — | $0 | 0 | SEC↗ |
| GUJRATHI SHEILA | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 80,000 | — | $0 | 0 | SEC↗ |
| GUJRATHI SHEILA | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 277,941 | — | $0 | 0 | SEC↗ |
| GUJRATHI SHEILA | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 662,369 | — | $0 | 0 | SEC↗ |
| HULME ALLISON | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 20,000 | — | $0 | 0 | SEC↗ |
| HULME ALLISON | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 33,000 | — | $0 | 0 | SEC↗ |
| HULME ALLISON | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 40,000 | — | $0 | 0 | SEC↗ |
| HULME ALLISON | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 15,937 | — | $0 | 0 | SEC↗ |
| HULME ALLISON | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 20,427 | — | $0 | 0 | SEC↗ |
| Cadoret-Manier Onaiza | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 20,000 | — | $0 | 0 | SEC↗ |
| Cadoret-Manier Onaiza | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 15,937 | — | $0 | 0 | SEC↗ |
| Cadoret-Manier Onaiza | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 20,427 | — | $0 | 0 | SEC↗ |
| Cadoret-Manier Onaiza | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 40,000 | — | $0 | 0 | SEC↗ |
| Cadoret-Manier Onaiza | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 33,000 | — | $0 | 0 | SEC↗ |
| Moore Matthew Richard | Chief Operating Officer | D To issuer deriv | 2026-03-04 | 2026-03-04 | 145,000 | — | $0 | 0 | SEC↗ |
| Moore Matthew Richard | Chief Operating Officer | D To issuer deriv | 2026-03-04 | 2026-03-04 | 320,000 | — | $0 | 0 | SEC↗ |
| White William Richard | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 40,000 | — | $0 | 0 | SEC↗ |
| White William Richard | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 33,000 | — | $0 | 0 | SEC↗ |
| White William Richard | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 15,937 | — | $0 | 0 | SEC↗ |
| White William Richard | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 21,825 | — | $0 | 0 | SEC↗ |
| White William Richard | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 119,120 | — | $0 | 0 | SEC↗ |
| White William Richard | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 20,000 | — | $0 | 0 | SEC↗ |
| Subramaniam Somu | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 21,825 | — | $0 | 0 | SEC↗ |
| Subramaniam Somu | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 20,000 | — | $0 | 0 | SEC↗ |
| Subramaniam Somu | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 15,937 | — | $0 | 0 | SEC↗ |
| Subramaniam Somu | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 33,000 | — | $0 | 0 | SEC↗ |
| Subramaniam Somu | Director | D To issuer deriv | 2026-03-04 | 2026-03-04 | 40,000 | — | $0 | 0 | SEC↗ |
| Gonzales Roy | Senior VP, Finance | D To issuer deriv | 2026-03-04 | 2026-03-04 | 17,500 | — | $0 | 0 | SEC↗ |
| Gonzales Roy | Senior VP, Finance | D To issuer deriv | 2026-03-04 | 2026-03-04 | 109,200 | — | $0 | 0 | SEC↗ |
| Gonzales Roy | Senior VP, Finance | D To issuer deriv | 2026-03-04 | 2026-03-04 | 70,000 | — | $0 | 0 | SEC↗ |
| Gonzales Roy | Senior VP, Finance | D To issuer deriv | 2026-03-04 | 2026-03-04 | 12,500 | — | $0 | 0 | SEC↗ |
| Gonzales Roy | Senior VP, Finance | D To issuer deriv | 2026-03-04 | 2026-03-04 | 37,500 | — | $0 | 0 | SEC↗ |
| Gonzales Roy | Senior VP, Finance | D To issuer deriv | 2026-03-04 | 2026-03-04 | 35,000 | — | $0 | 0 | SEC↗ |
| Forman Mark S | Chief Medical Officer | D To issuer | 2026-03-04 | 2026-03-04 | 6,000 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | D To issuer | 2026-03-04 | 2026-03-04 | 2,372,863 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | D To issuer | 2026-03-04 | 2026-03-04 | 489,481 | — | $0 | 0 | SEC↗ |
| GUJRATHI SHEILA | Director | D To issuer | 2026-03-04 | 2026-03-04 | 130,000 | — | $0 | 0 | SEC↗ |
| Subramaniam Somu | Director | D To issuer | 2026-03-04 | 2026-03-04 | 3,337,495 | — | $0 | 0 | SEC↗ |
| Gonzales Roy | Senior VP, Finance | D To issuer | 2026-03-04 | 2026-03-04 | 5,313 | — | $0 | 0 | SEC↗ |
| Subramaniam Somu | Director | J Other | 2026-02-27 | 2026-03-03 | 694,718 | — | $0 | 3,337,495 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-12-18 | 2025-12-19 | 12,675 | $7.72 | $97.9K | 489,481 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | S Sale | 2025-12-18 | 2025-12-19 | 47,345 | $7.72 | $365.5K | 2,372,863 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-12-17 | 2025-12-19 | 34,930 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | M Exercise deriv | 2025-12-17 | 2025-12-19 | 116,668 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-12-17 | 2025-12-19 | 34,930 | — | $0 | 502,156 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | M Exercise | 2025-12-17 | 2025-12-19 | 116,668 | — | $0 | 2,420,208 | SEC↗ |
| Gonzales Roy | Senior VP, Finance | A Award | 2025-11-17 | 2025-11-19 | 1,767 | $1.03 | $1.8K | 5,313 | SEC↗ |
| Forman Mark S | Chief Medical Officer | A Award | 2025-11-17 | 2025-11-19 | 3,000 | $1.03 | $3.1K | 6,000 | SEC↗ |
| Gujrathi Sheila | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| White William Richard | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Subramaniam Somu | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| HULME ALLISON | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Cadoret-Manier Onaiza | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Forman Mark S | Chief Medical Officer | A Award | 2025-05-15 | 2025-05-16 | 3,000 | $1.03 | $3.1K | 3,000 | SEC↗ |
| Gonzales Roy | Senior VP, Finance | A Award | 2025-05-15 | 2025-05-16 | 1,750 | $1.03 | $1.8K | 3,546 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | S Sale | 2025-04-02 | 2025-04-03 | 1,887 | $1.07 | $2.0K | 467,226 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2025-03-28 | 2025-04-01 | 4,531 | — | $0 | 9,063 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | M Exercise deriv | 2025-03-28 | 2025-04-01 | 11,844 | — | $0 | 23,688 | SEC↗ |
| Subramaniam Somu | Director | J Other | 2025-03-28 | 2025-04-01 | 1,335,450 | — | $0 | 4,032,213 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise | 2025-03-28 | 2025-04-01 | 4,531 | — | $0 | 469,113 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | M Exercise | 2025-03-28 | 2025-04-01 | 11,844 | — | $0 | 2,303,540 | SEC↗ |
| Subramaniam Somu | Director | J Other | 2025-03-10 | 2025-03-12 | 1,735,306 | — | $0 | 5,367,663 | SEC↗ |
| Forman Mark S | Chief Medical Officer | A Award deriv | 2025-01-02 | 2025-01-03 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Gonzales Roy | Senior VP, Finance | A Award deriv | 2025-01-02 | 2025-01-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Gonzales Roy | Senior VP, Finance | A Award deriv | 2025-01-02 | 2025-01-03 | 109,200 | — | $0 | 109,200 | SEC↗ |
| Moore Matthew Richard | Chief Operating Officer | A Award deriv | 2025-01-02 | 2025-01-03 | 145,000 | — | $0 | 145,000 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | A Award deriv | 2025-01-02 | 2025-01-03 | 700,000 | — | $0 | 700,000 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-01-02 | 2025-01-03 | 245,000 | — | $0 | 245,000 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-01-02 | 2025-01-03 | 170,104 | — | $0 | 170,104 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | S Sale | 2024-12-27 | 2024-12-30 | 21,119 | $2.36 | $49.8K | 464,582 | SEC↗ |
| Gujrathi Sheila | Director | P Buy | 2024-12-23 | 2024-12-26 | 130,000 | $2.31 | $300.3K | 130,000 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | S Sale | 2024-12-19 | 2024-12-19 | 13,161 | $2.26 | $29.7K | 485,701 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | M Exercise deriv | 2024-12-17 | 2024-12-19 | 116,668 | — | $0 | 116,668 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-12-17 | 2024-12-19 | 34,930 | — | $0 | 34,930 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | M Exercise | 2024-12-17 | 2024-12-19 | 116,668 | — | $0 | 2,291,696 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise | 2024-12-17 | 2024-12-19 | 34,930 | — | $0 | 498,862 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-12-10 | 2024-12-11 | 5,377 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-12-10 | 2024-12-11 | 193,557 | — | $0 | 0 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise | 2024-12-10 | 2024-12-11 | 193,557 | $0.20 | $38.7K | 463,932 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise | 2024-12-10 | 2024-12-11 | 5,377 | $0.20 | $1.1K | 270,375 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | P Buy | 2024-11-25 | 2024-11-25 | 261,752 | $2.01 | $526.1K | 2,175,028 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | P Buy | 2024-11-22 | 2024-11-25 | 238,248 | $1.83 | $436.0K | 1,913,276 | SEC↗ |
| Forman Mark S | Chief Medical Officer | A Award deriv | 2024-08-12 | 2024-08-13 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | J Other | 2024-06-24 | 2024-06-26 | 641,327 | — | $0 | 7,102,969 | SEC↗ |
| NSV Partners III GP LLC | 10% Owner | J Other | 2024-06-24 | 2024-06-26 | 641,327 | — | $0 | 7,102,969 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | M Exercise deriv | 2024-06-10 | 2024-06-11 | 96,778 | — | $0 | 0 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | M Exercise | 2024-06-10 | 2024-06-11 | 96,778 | $0.20 | $19.4K | 1,675,028 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | A Award deriv | 2024-06-06 | 2024-06-07 | 33,000 | — | $0 | 33,000 | SEC↗ |
| HULME ALLISON | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Gujrathi Sheila | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Cadoret-Manier Onaiza | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 33,000 | — | $0 | 33,000 | SEC↗ |
| White William Richard | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Moore Matthew Richard | Chief Operating Officer | A Award deriv | 2024-05-16 | 2024-05-17 | 320,000 | — | $0 | 320,000 | SEC↗ |
| NSV Partners III GP LLC | 10% Owner | J Other | 2024-04-12 | 2024-04-16 | 695,339 | — | $0 | 7,744,296 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | J Other | 2024-04-12 | 2024-04-16 | 695,339 | — | $0 | 7,744,296 | SEC↗ |
| Auster Martin | CHIEF FINANCIAL OFFICER | S Sale | 2024-04-02 | 2024-04-03 | 1,405 | $5.40 | $7.6K | 24,303 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | S Sale | 2024-04-02 | 2024-04-03 | 4,312 | $5.40 | $23.3K | 1,578,250 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | S Sale | 2024-04-02 | 2024-04-03 | 1,651 | $5.40 | $8.9K | 264,998 | SEC↗ |
| Krueger Christopher W | CHIEF BUSINESS OFFICER | S Sale | 2024-04-02 | 2024-04-03 | 1,651 | $5.40 | $8.9K | 284,999 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-03-28 | 2024-03-29 | 4,531 | — | $0 | 13,594 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | M Exercise deriv | 2024-03-28 | 2024-03-29 | 11,843 | — | $0 | 35,532 | SEC↗ |
| Auster Martin | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2024-03-28 | 2024-03-29 | 4,531 | — | $0 | 13,594 | SEC↗ |
| Krueger Christopher W | CHIEF BUSINESS OFFICER | M Exercise deriv | 2024-03-28 | 2024-03-29 | 4,531 | — | $0 | 13,594 | SEC↗ |
| Nuss John | CHIEF SCIENTIFIC OFFICER | M Exercise | 2024-03-28 | 2024-03-29 | 4,531 | — | $0 | 266,649 | SEC↗ |
| Mohan Raju | CEO AND PRESIDENT | M Exercise | 2024-03-28 | 2024-03-29 | 11,843 | — | $0 | 1,582,562 | SEC↗ |
| Auster Martin | CHIEF FINANCIAL OFFICER | M Exercise | 2024-03-28 | 2024-03-29 | 4,531 | — | $0 | 25,708 | SEC↗ |
| Krueger Christopher W | CHIEF BUSINESS OFFICER | M Exercise | 2024-03-28 | 2024-03-29 | 4,531 | — | $0 | 286,650 | SEC↗ |
| Gujrathi Sheila | Director | A Award deriv | 2024-01-21 | 2024-01-23 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Cadoret-Manier Onaiza | Director | A Award deriv | 2024-01-21 | 2024-01-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HULME ALLISON | Director | A Award deriv | 2024-01-21 | 2024-01-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | A Award deriv | 2024-01-21 | 2024-01-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| White William Richard | Director | A Award deriv | 2024-01-21 | 2024-01-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | A Award deriv | 2024-01-02 | 2024-01-03 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Nuss John | Chief Scientific Officer | A Award deriv | 2024-01-02 | 2024-01-03 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Mohan Raju | CEO and President | A Award deriv | 2024-01-02 | 2024-01-03 | 155,000 | — | $0 | 155,000 | SEC↗ |
| Auster Martin | Chief Financial Officer | A Award deriv | 2024-01-02 | 2024-01-03 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Mohan Raju | CEO and President | S Sale | 2023-12-20 | 2023-12-21 | 58,860 | $2.12 | $124.8K | 1,570,719 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-12-20 | 2023-12-21 | 5,293 | $2.12 | $11.2K | 282,119 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-12-20 | 2023-12-21 | 17,628 | $2.12 | $37.4K | 262,118 | SEC↗ |
| Auster Martin | Chief Financial Officer | A Award deriv | 2023-12-18 | 2023-12-19 | 181,250 | — | $0 | 181,250 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | A Award deriv | 2023-12-18 | 2023-12-19 | 181,250 | — | $0 | 181,250 | SEC↗ |
| Nuss John | Chief Scientific Officer | A Award deriv | 2023-12-18 | 2023-12-19 | 181,250 | — | $0 | 181,250 | SEC↗ |
| Mohan Raju | CEO and President | A Award deriv | 2023-12-18 | 2023-12-19 | 473,750 | — | $0 | 473,750 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise deriv | 2023-12-17 | 2023-12-19 | 10,479 | — | $0 | 20,958 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise deriv | 2023-12-17 | 2023-12-19 | 34,931 | — | $0 | 69,860 | SEC↗ |
| Mohan Raju | CEO and President | M Exercise deriv | 2023-12-17 | 2023-12-19 | 116,668 | — | $0 | 233,336 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise | 2023-12-17 | 2023-12-19 | 10,479 | — | $0 | 287,412 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise | 2023-12-17 | 2023-12-19 | 34,931 | — | $0 | 279,746 | SEC↗ |
| Mohan Raju | CEO and President | M Exercise | 2023-12-17 | 2023-12-19 | 116,668 | — | $0 | 1,629,579 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-10-09 | 2023-10-11 | 49,152 | $30.03 | $1.48M | 8,439,635 | SEC↗ |
| NSV Partners III GP LLC | 10% Owner | S Sale | 2023-10-09 | 2023-10-11 | 49,152 | $30.03 | $1.48M | 8,439,635 | SEC↗ |
| Mohan Raju | Chief Executive Officer | M Exercise deriv | 2023-10-05 | 2023-10-06 | 30,000 | — | $0 | 335,286 | SEC↗ |
| Mohan Raju | Chief Executive Officer | S Sale | 2023-10-05 | 2023-10-06 | 30,000 | $29.11 | $873.3K | 1,512,911 | SEC↗ |
| Mohan Raju | Chief Executive Officer | M Exercise | 2023-10-05 | 2023-10-06 | 30,000 | $8.04 | $241.2K | 1,542,911 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise deriv | 2023-10-03 | 2023-10-04 | 7,972 | — | $0 | 0 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise deriv | 2023-10-03 | 2023-10-04 | 627 | — | $0 | 192,777 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise deriv | 2023-10-03 | 2023-10-04 | 1,401 | — | $0 | 5,377 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise deriv | 2023-10-03 | 2023-10-04 | 15,000 | — | $0 | 104,371 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise | 2023-10-03 | 2023-10-04 | 1,401 | $0.20 | $280 | 246,216 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-10-03 | 2023-10-04 | 723 | $30.72 | $22.2K | 244,815 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-10-03 | 2023-10-04 | 9,277 | $29.94 | $277.8K | 245,538 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise | 2023-10-03 | 2023-10-04 | 627 | $8.04 | $5.0K | 254,815 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise | 2023-10-03 | 2023-10-04 | 7,972 | $3.54 | $28.2K | 254,188 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-10-03 | 2023-10-04 | 994 | $30.70 | $30.5K | 276,548 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-10-03 | 2023-10-04 | 14,006 | $29.93 | $419.2K | 277,542 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise | 2023-10-03 | 2023-10-04 | 15,000 | $8.04 | $120.6K | 291,548 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-09-18 | 2023-09-20 | 56,665 | $37.81 | $2.14M | 8,488,787 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-09-18 | 2023-09-20 | 56,665 | $37.81 | $2.14M | 8,488,787 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise deriv | 2023-09-05 | 2023-09-07 | 10,000 | — | $0 | 6,778 | SEC↗ |
| Mohan Raju | Chief Executive Officer | M Exercise deriv | 2023-09-05 | 2023-09-07 | 30,000 | — | $0 | 365,286 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise deriv | 2023-09-05 | 2023-09-07 | 15,000 | — | $0 | 119,371 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-09-05 | 2023-09-07 | 6,991 | $32.24 | $225.4K | 247,824 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-09-05 | 2023-09-07 | 3,009 | $33.41 | $100.5K | 244,815 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise | 2023-09-05 | 2023-09-07 | 10,000 | $0.20 | $2.0K | 254,815 | SEC↗ |
| Mohan Raju | Chief Executive Officer | S Sale | 2023-09-05 | 2023-09-07 | 20,630 | $32.25 | $665.3K | 1,522,281 | SEC↗ |
| Mohan Raju | Chief Executive Officer | M Exercise | 2023-09-05 | 2023-09-07 | 30,000 | $8.04 | $241.2K | 1,542,911 | SEC↗ |
| Mohan Raju | Chief Executive Officer | S Sale | 2023-09-05 | 2023-09-07 | 9,015 | $33.39 | $301.0K | 1,513,266 | SEC↗ |
| Mohan Raju | Chief Executive Officer | S Sale | 2023-09-05 | 2023-09-07 | 355 | $33.98 | $12.1K | 1,512,911 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-09-05 | 2023-09-07 | 4,546 | $33.42 | $151.9K | 276,571 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise | 2023-09-05 | 2023-09-07 | 15,000 | $8.04 | $120.6K | 291,548 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-09-05 | 2023-09-07 | 10,431 | $32.25 | $336.4K | 281,117 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-09-05 | 2023-09-07 | 23 | $33.97 | $781 | 276,548 | SEC↗ |
| Auster Martin | Chief Financial Officer | S Sale | 2023-09-05 | 2023-09-07 | 8,142 | $33.41 | $272.0K | 21,180 | SEC↗ |
| Auster Martin | Chief Financial Officer | S Sale | 2023-09-05 | 2023-09-07 | 3 | $33.98 | $102 | 21,177 | SEC↗ |
| Auster Martin | Chief Financial Officer | S Sale | 2023-09-05 | 2023-09-07 | 18,327 | $32.26 | $591.2K | 29,322 | SEC↗ |
| Sandborn William J. | See Remarks | M Exercise deriv | 2023-08-31 | 2023-09-01 | 11,900 | — | $0 | 664,300 | SEC↗ |
| Sandborn William J. | See Remarks | S Sale | 2023-08-31 | 2023-09-01 | 11,900 | $33.64 | $400.3K | 48,389 | SEC↗ |
| Sandborn William J. | See Remarks | M Exercise | 2023-08-31 | 2023-09-01 | 11,900 | $14.85 | $176.7K | 60,289 | SEC↗ |
| Sandborn William J. | See Remarks | S Sale | 2023-08-08 | 2023-08-08 | 2,086 | $32.69 | $68.2K | 25,602 | SEC↗ |
| Sandborn William J. | See Remarks | S Sale | 2023-08-08 | 2023-08-08 | 1,408 | $33.12 | $46.6K | 24,194 | SEC↗ |
| Mohan Raju | Chief Executive Officer | M Exercise deriv | 2023-08-07 | 2023-08-08 | 30,000 | — | $0 | 395,286 | SEC↗ |
| Mohan Raju | Chief Executive Officer | S Sale | 2023-08-07 | 2023-08-08 | 8,898 | $34.09 | $303.3K | 1,513,788 | SEC↗ |
| Mohan Raju | Chief Executive Officer | M Exercise | 2023-08-07 | 2023-08-08 | 30,000 | $8.04 | $241.2K | 1,542,911 | SEC↗ |
| Mohan Raju | Chief Executive Officer | S Sale | 2023-08-07 | 2023-08-08 | 20,225 | $33.20 | $671.5K | 1,522,686 | SEC↗ |
| Mohan Raju | Chief Executive Officer | S Sale | 2023-08-07 | 2023-08-08 | 877 | $35.01 | $30.7K | 1,512,911 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise deriv | 2023-08-03 | 2023-08-04 | 15,000 | — | $0 | 134,371 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise deriv | 2023-08-03 | 2023-08-04 | 10,000 | — | $0 | 16,778 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-08-03 | 2023-08-04 | 13,300 | $35.55 | $472.8K | 278,248 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise | 2023-08-03 | 2023-08-04 | 15,000 | $8.04 | $120.6K | 291,548 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-08-03 | 2023-08-04 | 1,700 | $35.91 | $61.0K | 276,548 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-08-03 | 2023-08-04 | 1,113 | $35.92 | $40.0K | 244,815 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-08-03 | 2023-08-04 | 8,887 | $35.56 | $316.0K | 245,928 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise | 2023-08-03 | 2023-08-04 | 10,000 | $0.20 | $2.0K | 254,815 | SEC↗ |
| Sandborn William J. | See Remarks | M Exercise deriv | 2023-07-31 | 2023-08-01 | 11,900 | — | $0 | 676,200 | SEC↗ |
| Sandborn William J. | See Remarks | M Exercise | 2023-07-31 | 2023-08-01 | 11,900 | $14.85 | $176.7K | 60,289 | SEC↗ |
| Sandborn William J. | See Remarks | S Sale | 2023-07-31 | 2023-08-01 | 11,900 | $37.16 | $442.2K | 48,389 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-31 | 2023-08-01 | 10,803 | $37.59 | $406.1K | 8,545,452 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-31 | 2023-08-01 | 10,803 | $37.59 | $406.1K | 8,545,452 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-28 | 2023-08-01 | 611 | $37.53 | $22.9K | 8,556,255 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-28 | 2023-08-01 | 611 | $37.53 | $22.9K | 8,556,255 | SEC↗ |
| Auster Martin | Chief Financial Officer | M Exercise deriv | 2023-07-25 | 2023-07-26 | 28,000 | — | $0 | 219,184 | SEC↗ |
| Auster Martin | Chief Financial Officer | S Sale | 2023-07-25 | 2023-07-26 | 28,000 | $35.54 | $995.1K | 47,649 | SEC↗ |
| Auster Martin | Chief Financial Officer | M Exercise | 2023-07-25 | 2023-07-26 | 28,000 | $3.45 | $96.6K | 75,649 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-12 | 2023-07-13 | 3,275 | $37.62 | $123.2K | 8,556,866 | SEC↗ |
| NSV Partners III GP LLC | 10% Owner | S Sale | 2023-07-12 | 2023-07-13 | 3,275 | $37.62 | $123.2K | 8,556,866 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-11 | 2023-07-13 | 28,646 | $37.54 | $1.08M | 8,560,141 | SEC↗ |
| NSV Partners III GP LLC | 10% Owner | S Sale | 2023-07-11 | 2023-07-13 | 28,646 | $37.54 | $1.08M | 8,560,141 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-07 | 2023-07-11 | 20,718 | $35.82 | $742.1K | 9,556,561 | SEC↗ |
| NSV Partners III LP | 10% Owner | J Other | 2023-07-07 | 2023-07-11 | 1,030,341 | — | $0 | 8,522,624 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-07 | 2023-07-11 | 3,596 | $36.93 | $132.8K | 9,552,965 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-07 | 2023-07-11 | 75,686 | $34.99 | $2.65M | 9,577,279 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-07 | 2023-07-11 | 75,686 | $34.99 | $2.65M | 9,577,279 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-07 | 2023-07-11 | 3,596 | $36.93 | $132.8K | 9,552,965 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | J Other | 2023-07-07 | 2023-07-11 | 1,030,341 | — | $0 | 8,522,624 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-07 | 2023-07-11 | 20,718 | $35.82 | $742.1K | 9,556,561 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-07 | 2023-07-19 | 75,686 | $34.99 | $2.65M | 9,577,279 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-07 | 2023-07-19 | 20,718 | $35.82 | $742.1K | 9,556,561 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-07 | 2023-07-19 | 3,596 | $36.93 | $132.8K | 9,552,965 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | J Other | 2023-07-07 | 2023-07-19 | 964,178 | — | $0 | 8,588,787 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-07 | 2023-07-19 | 3,596 | $36.93 | $132.8K | 9,552,965 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-07 | 2023-07-19 | 75,686 | $34.99 | $2.65M | 9,577,279 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-07 | 2023-07-19 | 20,718 | $35.82 | $742.1K | 9,556,561 | SEC↗ |
| NSV Partners III LP | 10% Owner | J Other | 2023-07-07 | 2023-07-19 | 964,178 | — | $0 | 8,588,787 | SEC↗ |
| Mohan Raju | Chief Executive Officer | M Exercise deriv | 2023-07-05 | 2023-07-05 | 29,785 | — | $0 | 425,286 | SEC↗ |
| Mohan Raju | Chief Executive Officer | S Sale | 2023-07-05 | 2023-07-05 | 5,920 | $39.72 | $235.1K | 1,513,034 | SEC↗ |
| Mohan Raju | Chief Executive Officer | S Sale | 2023-07-05 | 2023-07-05 | 6,659 | $38.78 | $258.2K | 1,518,954 | SEC↗ |
| Mohan Raju | Chief Executive Officer | S Sale | 2023-07-05 | 2023-07-05 | 123 | $40.32 | $5.0K | 1,512,911 | SEC↗ |
| Mohan Raju | Chief Executive Officer | M Exercise | 2023-07-05 | 2023-07-05 | 29,785 | $8.04 | $239.5K | 1,542,911 | SEC↗ |
| Mohan Raju | Chief Executive Officer | S Sale | 2023-07-05 | 2023-07-05 | 17,298 | $37.74 | $652.8K | 1,525,613 | SEC↗ |
| Sandborn William J. | See Remarks | M Exercise deriv | 2023-07-03 | 2023-07-05 | 11,900 | — | $0 | 688,100 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise deriv | 2023-07-03 | 2023-07-05 | 20,000 | — | $0 | 26,778 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise deriv | 2023-07-03 | 2023-08-04 | 13,911 | — | $0 | 0 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise deriv | 2023-07-03 | 2023-08-04 | 1,089 | — | $0 | 149,371 | SEC↗ |
| Sandborn William J. | See Remarks | S Sale | 2023-07-03 | 2023-07-05 | 11,900 | $40.00 | $476.0K | 48,389 | SEC↗ |
| Sandborn William J. | See Remarks | M Exercise | 2023-07-03 | 2023-07-05 | 11,900 | $14.85 | $176.7K | 60,289 | SEC↗ |
| Sandborn William J. | See Remarks | S Sale | 2023-07-03 | 2023-07-05 | 3,487 | $40.00 | $139.5K | 27,688 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-07-03 | 2023-07-05 | 2,150 | $38.79 | $83.4K | 286,781 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-07-03 | 2023-07-05 | 1,960 | $38.05 | $74.6K | 288,931 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-07-03 | 2023-07-05 | 40 | $35.50 | $1.4K | 290,891 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-07-03 | 2023-07-05 | 214 | $34.72 | $7.4K | 290,931 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-07-03 | 2023-07-05 | 403 | $33.57 | $13.5K | 291,145 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | S Sale | 2023-07-03 | 2023-07-05 | 10,233 | $39.87 | $408.0K | 276,548 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise | 2023-07-03 | 2023-07-05 | 13,911 | $0.20 | $2.8K | 291,548 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise | 2023-07-03 | 2023-07-05 | 1,089 | $8.04 | $8.8K | 277,637 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-07-03 | 2023-07-05 | 15,682 | $39.96 | $626.7K | 244,815 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-07-03 | 2023-07-05 | 1,563 | $39.33 | $61.5K | 260,497 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-07-03 | 2023-07-05 | 2,266 | $38.32 | $86.8K | 262,060 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-07-03 | 2023-07-05 | 20 | $35.27 | $705 | 264,326 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-07-03 | 2023-07-05 | 142 | $34.72 | $4.9K | 264,346 | SEC↗ |
| Nuss John | Chief Scientific Officer | S Sale | 2023-07-03 | 2023-07-05 | 327 | $33.54 | $11.0K | 264,488 | SEC↗ |
| Nuss John | Chief Scientific Officer | M Exercise | 2023-07-03 | 2023-07-05 | 20,000 | $0.20 | $4.0K | 264,815 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-03 | 2023-07-06 | 14,331 | $37.64 | $539.4K | 9,756,415 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-03 | 2023-07-06 | 5,043 | $35.48 | $178.9K | 9,782,002 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-03 | 2023-07-06 | 11,256 | $36.78 | $414.0K | 9,770,746 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-03 | 2023-07-06 | 80,882 | $39.76 | $3.22M | 9,652,965 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-07-03 | 2023-07-06 | 22,568 | $39.05 | $881.3K | 9,733,847 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-03 | 2023-07-06 | 11,256 | $36.78 | $414.0K | 9,770,746 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-03 | 2023-07-06 | 5,043 | $35.48 | $178.9K | 9,782,002 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-03 | 2023-07-06 | 14,331 | $37.64 | $539.4K | 9,756,415 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-03 | 2023-07-06 | 22,568 | $39.05 | $881.3K | 9,733,847 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-07-03 | 2023-07-06 | 80,882 | $39.76 | $3.22M | 9,652,965 | SEC↗ |
| Sandborn William J. | See Remarks | M Exercise deriv | 2023-06-23 | 2023-06-27 | 10,790 | — | $0 | 0 | SEC↗ |
| Sandborn William J. | See Remarks | M Exercise | 2023-06-23 | 2023-06-27 | 10,790 | $0.20 | $2.2K | 59,179 | SEC↗ |
| Sandborn William J. | See Remarks | S Sale | 2023-06-23 | 2023-06-27 | 2,115 | $32.10 | $67.9K | 57,064 | SEC↗ |
| Sandborn William J. | See Remarks | S Sale | 2023-06-23 | 2023-06-27 | 8,675 | $32.85 | $285.0K | 48,389 | SEC↗ |
| HULME ALLISON | Director | A Award deriv | 2023-06-15 | 2023-06-16 | 15,937 | — | $0 | 15,937 | SEC↗ |
| Cadoret-Manier Onaiza | Director | A Award deriv | 2023-06-15 | 2023-06-16 | 15,937 | — | $0 | 15,937 | SEC↗ |
| Sandborn William J. | See Remarks | S Sale | 2023-06-15 | 2023-06-16 | 2,383 | $33.88 | $80.7K | 32,279 | SEC↗ |
| Sandborn William J. | See Remarks | S Sale | 2023-06-15 | 2023-06-16 | 1,104 | $34.75 | $38.4K | 31,175 | SEC↗ |
| NSV Partners III LP | 10% Owner | S Sale | 2023-06-14 | 2023-06-16 | 50,000 | $35.08 | $1.75M | 9,787,045 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-06-14 | 2023-06-16 | 50,000 | $35.08 | $1.75M | 9,787,045 | SEC↗ |
| White William Richard | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 15,937 | — | $0 | 15,937 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | A Award deriv | 2023-06-08 | 2023-06-12 | 15,937 | — | $0 | 15,937 | SEC↗ |
| Gujrathi Sheila | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 15,937 | — | $0 | 15,937 | SEC↗ |
| NSV Partners III GP LLC | 10% Owner | S Sale | 2023-06-07 | 2023-06-08 | 25,801 | $35.48 | $915.4K | 9,847,116 | SEC↗ |
| NSV Partners III GP LLC | 10% Owner | S Sale | 2023-06-07 | 2023-06-08 | 10,071 | $36.10 | $363.6K | 9,837,045 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-06-07 | 2023-06-08 | 10,071 | $36.10 | $363.6K | 9,837,045 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-06-07 | 2023-06-08 | 25,801 | $35.48 | $915.4K | 9,847,116 | SEC↗ |
| Auster Martin | Chief Financial Officer | M Exercise deriv | 2023-06-06 | 2023-06-07 | 28,000 | — | $0 | 247,184 | SEC↗ |
| Auster Martin | Chief Financial Officer | S Sale | 2023-06-06 | 2023-06-07 | 24,246 | $34.59 | $838.7K | 51,403 | SEC↗ |
| Auster Martin | Chief Financial Officer | S Sale | 2023-06-06 | 2023-06-07 | 3,754 | $34.95 | $131.2K | 47,649 | SEC↗ |
| Auster Martin | Chief Financial Officer | M Exercise | 2023-06-06 | 2023-06-07 | 28,000 | $3.45 | $96.6K | 75,649 | SEC↗ |
| NSV Partners III GP LLC | 10% Owner | S Sale | 2023-06-06 | 2023-06-08 | 4,128 | $35.00 | $144.5K | 9,872,917 | SEC↗ |
| Subramaniam Somu | Director, 10% Owner | S Sale | 2023-06-06 | 2023-06-08 | 4,128 | $35.00 | $144.5K | 9,872,917 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise deriv | 2023-06-05 | 2023-07-05 | 13,911 | — | $0 | 0 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise deriv | 2023-06-05 | 2023-07-05 | 1,089 | — | $0 | 149,371 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise deriv | 2023-06-05 | 2023-06-06 | 4,716 | — | $0 | 150,460 | SEC↗ |
| Krueger Christopher W | Chief Business Officer | M Exercise deriv | 2023-06-05 | 2023-06-06 | 10,284 | — | $0 | 13,911 | SEC↗ |